The decreased association between late age at menopause (≥50 years) and BC risk or no association in BRCA1/2 mutation carriers and non-carriers with FH were reported [10, 32], because hereditary or familial BC develops earlier than in the general population [10, 33]. This evidence concerns the gene BRCA1 and breast cancer.